Clinical trial
Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
NCT00035477 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
- Lead sponsor
- Forest Laboratories
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2000
- Completion date
- October 31, 2003
- Enrollment
- 446 (actual)
- Sites
- 82
Conditions
As the registry lists them; a condition with its own page is linked.